Vineet Laboratories Limited has successfully completed the allotment of equity shares through its rights issue, marking a significant milestone in the company's capital expansion plans. The Rights Issue Committee of the Board of Directors approved the allotment on February 02, 2026, in compliance with regulatory requirements.

Rights Issue Details

The company allotted 99,87,258 equity shares with a face value of Rs.10 each through the rights issue mechanism. The shares were priced at Rs.30 per equity share, which includes a premium of Rs.20 per share above the face value.

Capital Structure Transformation

The rights issue has resulted in a substantial increase in the company's paid-up share capital. The allotment more than doubled the company's equity base, reflecting strong investor participation in the offering.

Regulatory Compliance and Process

The allotment was conducted in accordance with the terms outlined in the Letter of Offer dated December 17, 2025. The basis of allotment was finalized in consultation with Bigshare Services Private Limited, which served as the Registrar to the Issue. BSE Limited acted as the designated stock exchange for the rights issue, providing regulatory oversight and approval for the allotment process.

The company has fulfilled its disclosure obligations under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Rights Issue Committee meeting commenced at 5:35 PM and concluded at 5:45 PM on February 02, 2026, demonstrating efficient decision-making processes.

Corporate Structure

Vineet Laboratories Limited, incorporated under CIN L24304TG2016PLC112888, operates from its registered office in Hyderabad. The company maintains its listing on both BSE Limited (Scrip Code: 543298) and National Stock Exchange of India Limited (Scrip Code: VINEETLAB), ensuring broad market accessibility for investors.

Vineet Laboratories Limited has announced a revision to its rights issue timeline, extending key dates to provide additional time for investors to participate in the offering.

Rights Issue Committee Decision

The Rights Issue Committee of the Board of Directors convened on January 13, 2026, from 12:00 Noon to 1:00 P.M. to deliberate on the rights issue schedule. The committee unanimously decided to extend both the last date for on-market renunciation and the issue closing date for the benefit of investors.

Revised Timeline Details

The company has modified two critical dates in its rights issue schedule:

Complete Revised Issue Schedule

The comprehensive timeline for the rights issue now follows this updated schedule:

Important Guidelines for Shareholders

The company has provided specific instructions for eligible equity shareholders regarding the renunciation process. Shareholders opting for off-market transfer renunciation must ensure completion of the process such that rights entitlements are credited to the demat account of the renouncee on or before the issue closing date of January 30, 2026.

Regulatory Compliance

This announcement has been made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has duly informed both BSE Limited (Scrip Code: 543298) and National Stock Exchange of India Limited (Scrip Code: VINEETLAB) about these timeline modifications. The decision was communicated by Managing Director Gaddam Venkata Ramana (DIN: 00031873) through official regulatory filings.